MicroSalt shares jumped on Monday after the low-sodium salt producer said 2025 sales exceeded management expectations and reaffirmed bumper revenue forecasts for 2026 and 2027.
The Tekcapital portfolio company announced that unaudited sales for the financial year ended 31 December 2025 reached $2.14 million, surpassing the board’s original target of $2.0 million and representing a 287% year-on-year increase from $745,000 in 2024.
MicroSalt shares were 9% higher at 51p at the time of writing.
The manufacturer of full-flavour natural salt containing approximately 50% less sodium said its B2B bulk business continues to advance, with strong growth driven by increased demand from its North American customer base.
Most interestingly for investors, the company projects sales of $7.0 million for 2026 based on current volume estimations and existing customer relationships, with revenue expected to exceed $15.0 million in 2027.
Although more is needed to understand margins as volumes scale significantly, MicroSalt’s current market cap of £29m will look very good value if these revenue forecasts are met.
Increased Volumes
MicroSalt highlighted continued momentum with Customer 3, one of the world’s largest food, soft drink, and snack manufacturers.
Following increased volume projections throughout 2025, a new product line is scheduled to launch in Q2 2026. The company has already delivered its first bulk order for this product to a specific end retailer of Customer 3, with further orders received on a broadly monthly basis, in line with management expectations.
“We are immensely proud to have exceeded Board expectations in 2025, delivering revenue growth of 287% compared to 2024,” said Rick Guiney, CEO of MicroSalt.
“This performance is a clear testament to the strength of our offering, the versatility of MicroSalt’s applications, and the successful execution of our strategy to build a sustainable and profitable organisation. Importantly, it reinforces our commitment to delivering healthier food alternatives globally while driving revenue growth and long-term value for our shareholders. Our final 2025 healthy servings totalled 830,735,462, providing clear evidence that MicroSalt is successfully delivering on its mission of enabling healthier foods by helping to reduce excess sodium consumption.
“We look forward to continuing our close collaboration with existing partners as we deepen relationships and expand our global reach. At the same time, we remain focused on establishing new partnerships that will support our next phase of growth. As we look ahead, we are confident in our ability to build on this momentum and continue strengthening the business for the benefit of both our customers and shareholders.”